These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12617184)

  • 1. Intravenous immunoglobulin in Australia. Supply and demand.
    Penny R
    Vox Sang; 2002 Aug; 83 Suppl 1():447-51. PubMed ID: 12617184
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with intravenous immunoglobulin is not a panacea but should be limited to those who can benefit.
    Ganly P; Spearing R
    N Z Med J; 2006 Dec; 119(1246):U2335. PubMed ID: 17151709
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute idiopathic thrombocytopenic purpura--management in childhood.
    Bolton-Maggs PH
    Blood; 1997 Feb; 89(4):1465; author reply 1466. PubMed ID: 9028974
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of idiopathic thrombocytopenic purpura in elderly patients.
    Andrès E; Daou S; Zimmer J; Federici L; Maloisel F
    Eur J Haematol; 2007 Feb; 78(2):175. PubMed ID: 17313565
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of intravenous immunoglobulin for treatment of dermatological conditions in Australia: A review.
    Smith SD; Dennington PM; Cooper A
    Australas J Dermatol; 2010 Nov; 51(4):227-37. PubMed ID: 21198517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subacute stent thrombosis in a patient with idiopathic thrombocytopenic purpura treated with intravenous immunoglobulin].
    Hidalgo-Urbano R; Carrascosa-Rosillo C; Martínez-Quesada M; González-Valdayo M
    Rev Esp Cardiol; 2008 Mar; 61(3):329-31. PubMed ID: 18361912
    [No Abstract]   [Full Text] [Related]  

  • 7. How far should we go with cost-utility analysis when treating children with acute idiopathic thrombocytopenic purpura?
    Benesch M
    Pediatr Blood Cancer; 2008 Feb; 50(2):433. PubMed ID: 17458876
    [No Abstract]   [Full Text] [Related]  

  • 8. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey.
    Marks MK; Vadamalayan B; Ekert H; South MJ
    J Paediatr Child Health; 2005; 41(1-2):52-5. PubMed ID: 15670225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group.
    Constantine MM; Thomas W; Whitman L; Kahwash E; Dolan S; Smith S; Caudle CJ; Burton E; Anderson DR;
    Transfusion; 2007 Nov; 47(11):2072-80. PubMed ID: 17958537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pocketbook: Pharmacoeconomic issues related to intravenous immunoglobulin therapy.
    Mahadevia PJ
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):94S-100S. PubMed ID: 16229680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antenatal intravenous immunoglobulin in chronic immune thrombocytopenic purpura: case report and literature review.
    Howman RA; Barr AL; Shand AW; Dickinson JE
    Fetal Diagn Ther; 2009; 25(1):93-7. PubMed ID: 19218809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
    Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
    Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of adult idiopathic thrombocytopenic purpura.
    Nakhoul IN; Kozuch P; Varma M
    Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of idiopathic thrombocytopenic purpura in children: the experience of 92 cases].
    Wang YC; Hu LQ; Zhang JS
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):486-8. PubMed ID: 17937865
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid intravenous immunoglobulin infusions in children with idiopathic thrombocytopenic purpura.
    Rajantie J; Mäkipernaa A; Lanning M
    Eur J Pediatr; 1994 Nov; 153(11):862. PubMed ID: 7843205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of idiopathic thrombopenic purpura in adolescents by intravenous immunoglobulin].
    Rodríguez Cuartero A; González Martínez F
    An Med Interna; 1998 Dec; 15(12):675-6. PubMed ID: 9972611
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of action of IVIG and anti-D in ITP.
    Lazarus AH; Crow AR
    Transfus Apher Sci; 2003 Jun; 28(3):249-55. PubMed ID: 12725951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of intravenous immunoglobulin in treatment of neoplasms and hematologic disorders in children].
    Wróbel G; Chybicka A; Kazanowska B
    Postepy Hig Med Dosw; 2002; 56 Suppl():59-68. PubMed ID: 12661416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept.
    Litton G
    Am J Hematol; 2008 Apr; 83(4):344. PubMed ID: 18186526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.